Cerity Partners’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $182K | Hold |
53,057
| – | – | ﹤0.01% | 2378 |
|
2025
Q1 | $118K | Hold |
53,057
| – | – | ﹤0.01% | 2298 |
|
2024
Q4 | $145K | Hold |
53,057
| – | – | ﹤0.01% | 2290 |
|
2024
Q3 | $138K | Buy |
53,057
+32,500
| +158% | +$84.5K | ﹤0.01% | 2387 |
|
2024
Q2 | $60.8K | Sell |
20,557
-18,000
| -47% | -$53.3K | ﹤0.01% | 2156 |
|
2024
Q1 | $175K | Buy |
38,557
+18,000
| +88% | +$81.5K | ﹤0.01% | 2135 |
|
2023
Q4 | $117K | Hold |
20,557
| – | – | ﹤0.01% | 1768 |
|
2023
Q3 | $94.6K | Hold |
20,557
| – | – | ﹤0.01% | 1331 |
|
2023
Q2 | $133K | Buy |
+20,557
| New | +$133K | ﹤0.01% | 1523 |
|
2021
Q3 | – | Sell |
-17,000
| Closed | -$374K | – | 683 |
|
2021
Q2 | $374K | Buy |
+17,000
| New | +$374K | 0.01% | 527 |
|